{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:17:29Z","timestamp":1791307049477,"version":"4.3.1"},"reference-count":59,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,2,6]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>Immune stimulation of cyclin D1 transgenic mice bearing Bim-deficient B cells induces an MCL phenotype. The induced lymphoma of E\u03bcCycD1CD19CREBimfl\/fl mice highlights the collaborative roles of Bim deletion and cyclin D1 expression in MCL.<\/jats:p>","DOI":"10.1182\/blood-2013-04-499079","type":"journal-article","created":{"date-parts":[[2013,12,19]],"date-time":"2013-12-19T07:40:27Z","timestamp":1387438827000},"page":"884-893","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":39,"title":["Mantle cell lymphoma in cyclin D1 transgenic mice with Bim-deficient B cells"],"prefix":"10.1182","volume":"123","author":[{"given":"Samuel G.","family":"Katz","sequence":"first","affiliation":[{"name":"Department of Pediatric Oncology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA;"},{"name":"Department of Pathology, Yale School of Medicine, New Haven, CT; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"LaBelle","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yale School of Medicine, New Haven, CT; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina P.","family":"Valeriano","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill K.","family":"Fisher","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott J.","family":"Rodig","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Kleinstein","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yale School of Medicine, New Haven, CT; and"},{"name":"Interdepartmental Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren D.","family":"Walensky","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111818042360200_B1","volume-title":"World Health Organization. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008","edition":"4th ed"},{"issue":"3","key":"2019111818042360200_B2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0092-8674(93)90137-F","article-title":"Physical interaction of the retinoblastoma protein with human D cyclins.","volume":"73","author":"Dowdy","year":"1993","journal-title":"Cell"},{"issue":"9","key":"2019111818042360200_B3","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/j.1460-2075.1994.tb06488.x","article-title":"Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene.","volume":"13","author":"Bodrug","year":"1994","journal-title":"EMBO J"},{"issue":"15","key":"2019111818042360200_B4","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1002\/j.1460-2075.1994.tb06655.x","article-title":"Cyclin D1\/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice.","volume":"13","author":"Lovec","year":"1994","journal-title":"EMBO J"},{"issue":"1","key":"2019111818042360200_B5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1182\/blood-2006-06-026500","article-title":"Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas.","volume":"109","author":"Mestre-Escorihuela","year":"2007","journal-title":"Blood"},{"issue":"8","key":"2019111818042360200_B6","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/sj.onc.1208300","article-title":"Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM.","volume":"24","author":"Tagawa","year":"2005","journal-title":"Oncogene"},{"issue":"4","key":"2019111818042360200_B7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.5858\/2003-127-0424-COMCLC","article-title":"Characterization of 4 mantle cell lymphoma cell lines.","volume":"127","author":"Amin","year":"2003","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"2019111818042360200_B8","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1182\/blood-2006-07-034173","article-title":"The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak.","volume":"109","author":"P\u00e9rez-Gal\u00e1n","year":"2007","journal-title":"Blood"},{"issue":"2","key":"2019111818042360200_B9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cancergencyto.2004.01.006","article-title":"Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519.","volume":"153","author":"Rudolph","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"issue":"18","key":"2019111818042360200_B10","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.1158\/1078-0432.CCR-11-0955","article-title":"ABT-737 induces apoptosis in mantle cell lymphoma cells with a Bcl-2high\/Mcl-1low profile and synergizes with other antineoplastic agents.","volume":"17","author":"Touzeau","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2019111818042360200_B11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/path.1768","article-title":"Expression of the NF-kappaB targets BCL2 and BIRC5\/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.","volume":"206","author":"Tracey","year":"2005","journal-title":"J Pathol"},{"issue":"30","key":"2019111818042360200_B12","doi-asserted-by":"crossref","first-page":"12461","DOI":"10.1073\/pnas.1018941108","article-title":"A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma.","volume":"108","author":"Beltran","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2019111818042360200_B13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4049\/jimmunol.171.1.88","article-title":"Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis.","volume":"171","author":"Pham","year":"2003","journal-title":"J Immunol"},{"issue":"1","key":"2019111818042360200_B14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/path.1254","article-title":"Expression of Mcl-1 in mantle cell lymphoma is associated with high-grade morphology, a high proliferative state, and p53 overexpression.","volume":"199","author":"Khoury","year":"2003","journal-title":"J Pathol"},{"issue":"4","key":"2019111818042360200_B15","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1158\/1535-7163.MCT-07-0302","article-title":"Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-kappaB, p53, bax, and p27 levels.","volume":"7","author":"Tucker","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"2019111818042360200_B16","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1172\/JCI46231","article-title":"A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers.","volume":"122","author":"LaBelle","year":"2012","journal-title":"J Clin Invest"},{"issue":"2","key":"2019111818042360200_B17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets.","volume":"19","author":"Souers","year":"2013","journal-title":"Nat Med"},{"issue":"12","key":"2019111818042360200_B18","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/01.MP.0000037310.82136.99","article-title":"Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features.","volume":"15","author":"Hao","year":"2002","journal-title":"Mod Pathol"},{"issue":"7","key":"2019111818042360200_B19","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.onc.1209147","article-title":"Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma.","volume":"25","author":"Gladden","year":"2006","journal-title":"Oncogene"},{"issue":"11","key":"2019111818042360200_B20","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1182\/blood-2006-08-039859","article-title":"Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.","volume":"109","author":"Wiestner","year":"2007","journal-title":"Blood"},{"issue":"11","key":"2019111818042360200_B21","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1182\/blood-2006-08-038497","article-title":"Development of a murine model for blastoid variant mantle-cell lymphoma.","volume":"109","author":"Ford","year":"2007","journal-title":"Blood"},{"issue":"5","key":"2019111818042360200_B22","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.leu.2404177","article-title":"Murine model for mantle cell lymphoma.","volume":"20","author":"Smith","year":"2006","journal-title":"Leukemia"},{"issue":"32","key":"2019111818042360200_B23","doi-asserted-by":"crossref","first-page":"11272","DOI":"10.1073\/pnas.0504783102","article-title":"Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune disease.","volume":"102","author":"Takeuchi","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2019111818042360200_B24","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/nar\/25.10.1913","article-title":"Rapid methods for the analysis of immunoglobulin gene hypermutation: application to transgenic and gene targeted mice.","volume":"25","author":"Jolly","year":"1997","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"2019111818042360200_B25","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/bioinformatics\/btn224","article-title":"lumi: a pipeline for processing Illumina microarray.","volume":"24","author":"Du","year":"2008","journal-title":"Bioinformatics"},{"key":"2019111818042360200_B26","author":"Gentleman"},{"issue":"18","key":"2019111818042360200_B27","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1093\/nar\/gkt660","article-title":"Quantitative set analysis for gene expression: a method to quantify gene set differential expression including gene-gene correlations.","volume":"41","author":"Yaari","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2019111818042360200_B28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma.","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"issue":"1","key":"2019111818042360200_B29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository.","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res"},{"issue":"24","key":"2019111818042360200_B30","first-page":"5640","article-title":"High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies.","volume":"58","author":"Avet-Loiseau","year":"1998","journal-title":"Cancer Res"},{"issue":"5445","key":"2019111818042360200_B31","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1126\/science.286.5445.1735","article-title":"Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity.","volume":"286","author":"Bouillet","year":"1999","journal-title":"Science"},{"issue":"2","key":"2019111818042360200_B32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3960\/jslrt.46.73","article-title":"In situ observation of germinal center cell apoptosis during a secondary immune response.","volume":"46","author":"Saitoh","year":"2006","journal-title":"J Clin Exp Hematop"},{"issue":"3","key":"2019111818042360200_B33","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0092-8674(93)90136-E","article-title":"Functional interactions of the retinoblastoma protein with mammalian D-type cyclins.","volume":"73","author":"Ewen","year":"1993","journal-title":"Cell"},{"issue":"3","key":"2019111818042360200_B34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1101\/gad.7.3.331","article-title":"Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.","volume":"7","author":"Kato","year":"1993","journal-title":"Genes Dev"},{"issue":"3","key":"2019111818042360200_B35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0092-8674(95)90385-2","article-title":"The retinoblastoma protein and cell cycle control.","volume":"81","author":"Weinberg","year":"1995","journal-title":"Cell"},{"issue":"20","key":"2019111818042360200_B36","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM199911113412007","article-title":"Cellular origin of human B-cell lymphomas.","volume":"341","author":"K\u00fcppers","year":"1999","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111818042360200_B37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1034\/j.1600-0609.2002.01662.x","article-title":"Somatic hypermutation and V(H) gene usage in mantle cell lymphoma.","volume":"68","author":"Thors\u00e9lius","year":"2002","journal-title":"Eur J Haematol"},{"issue":"15","key":"2019111818042360200_B38","first-page":"4398","article-title":"Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells.","volume":"62","author":"Ek","year":"2002","journal-title":"Cancer Res"},{"issue":"2","key":"2019111818042360200_B39","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.jid.5700989","article-title":"Bim expression is reduced in human cutaneous melanomas.","volume":"128","author":"Dai","year":"2008","journal-title":"J Invest Dermatol"},{"issue":"4","key":"2019111818042360200_B40","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nm.2713","article-title":"A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer.","volume":"18","author":"Ng","year":"2012","journal-title":"Nat Med"},{"issue":"18","key":"2019111818042360200_B41","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1158\/1078-0432.CCR-07-5202","article-title":"Prognostic impact of bim, puma, and noxa expression in human colon carcinomas.","volume":"14","author":"Sinicrope","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"49","key":"2019111818042360200_B42","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.1038\/sj.onc.1210510","article-title":"Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance.","volume":"26","author":"Zantl","year":"2007","journal-title":"Oncogene"},{"issue":"5","key":"2019111818042360200_B43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ccr.2006.03.027","article-title":"Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members.","volume":"9","author":"Certo","year":"2006","journal-title":"Cancer Cell"},{"issue":"3","key":"2019111818042360200_B44","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2004.12.030","article-title":"Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function.","volume":"17","author":"Chen","year":"2005","journal-title":"Mol Cell"},{"issue":"7216","key":"2019111818042360200_B45","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/nature07396","article-title":"BAX activation is initiated at a novel interaction site.","volume":"455","author":"Gavathiotis","year":"2008","journal-title":"Nature"},{"issue":"4","key":"2019111818042360200_B46","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.molcel.2005.02.003","article-title":"BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly.","volume":"17","author":"Kuwana","year":"2005","journal-title":"Mol Cell"},{"issue":"11","key":"2019111818042360200_B47","doi-asserted-by":"crossref","first-page":"E986","DOI":"10.1073\/pnas.1214313110","article-title":"Direct activation of full-length proapoptotic BAK.","volume":"110","author":"Leshchiner","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"46","key":"2019111818042360200_B48","doi-asserted-by":"crossref","first-page":"19503","DOI":"10.1073\/pnas.0905056106","article-title":"Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition.","volume":"106","author":"Faber","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"39","key":"2019111818042360200_B49","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1038\/onc.2011.111","article-title":"Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification.","volume":"30","author":"Tanizaki","year":"2011","journal-title":"Oncogene"},{"issue":"11","key":"2019111818042360200_B50","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1172\/JCI35437","article-title":"Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic.","volume":"118","author":"Cragg","year":"2008","journal-title":"J Clin Invest"},{"issue":"4","key":"2019111818042360200_B51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ni1575","article-title":"Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes.","volume":"9","author":"Xiao","year":"2008","journal-title":"Nat Immunol"},{"issue":"13","key":"2019111818042360200_B52","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1084\/jem.20061552","article-title":"Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction.","volume":"203","author":"Erlacher","year":"2006","journal-title":"J Exp Med"},{"issue":"16","key":"2019111818042360200_B53","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1073\/pnas.0401471101","article-title":"Bim is a suppressor of Myc-induced mouse B cell leukemia.","volume":"101","author":"Egle","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2019111818042360200_B54","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ccr.2005.02.008","article-title":"Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy.","volume":"7","author":"Tan","year":"2005","journal-title":"Cancer Cell"},{"issue":"1","key":"2019111818042360200_B55","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2141.2011.09010.x","article-title":"Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL.","volume":"157","author":"Kern","year":"2012","journal-title":"Br J Haematol"},{"issue":"12","key":"2019111818042360200_B56","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1158\/1078-0432.CCR-10-3412","article-title":"Vorinostat-induced apoptosis in mantle cell lymphoma is mediated by acetylation of proapoptotic BH3-only gene promoters.","volume":"17","author":"Xargay-Torrent","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2019111818042360200_B57","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1182\/blood-2007-12-130781","article-title":"The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies.","volume":"112","author":"Paoluzzi","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2019111818042360200_B58","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1172\/JCI28281","article-title":"Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737.","volume":"117","author":"Del Gaizo Moore","year":"2007","journal-title":"J Clin Invest"},{"issue":"7","key":"2019111818042360200_B59","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nchembio.995","article-title":"Direct and selective small-molecule activation of proapoptotic BAX.","volume":"8","author":"Gavathiotis","year":"2012","journal-title":"Nat Chem Biol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/123\/6\/884\/1379127\/884.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/123\/6\/884\/1379127\/884.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T07:16:30Z","timestamp":1647760590000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/123\/6\/884\/32607\/Mantle-cell-lymphoma-in-cyclin-D1-transgenic-mice"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,6]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,2,6]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2013-04-499079","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,6]]}}}